American Portfolios Advisors - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 43 filers reported holding PSYCHEMEDICS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2020$1,887
-8.3%
3400.0%0.00%
Q1 2020$2,057
-33.9%
3400.0%0.00%
Q4 2019$3,111
+0.5%
3400.0%0.00%
Q3 2019$3,097
+34.0%
340
+48.5%
0.00%
Q2 2019$2,311
+18.5%
229
+64.7%
0.00%
Q1 2019$1,950
-11.6%
1390.0%0.00%
Q4 2018$2,2061390.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders